For-profit organizations · Montréal, Quebec
NexPlasmaGen Incorporée
- Total value
- $619K
- Agreements
- 5
- Programs
- 3
- First and latest
- 2018–2026
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026. Agreements under programs that mostly fund individuals are not listed under any name.
See this recipient’s records on the government’s search
Applying for the same funding? NRC IRAP Financial Assistance (apply through the funder’s page; no deadline stated). Deadlines, who can apply and who else got it.
By program
| Program | Department | Agreements | Total |
|---|---|---|---|
| Industrial Research Assistance Program – Contributions to Firms | National Research Council Canada | 3 | $372K |
| Industrial Research Assistance Program | National Research Council Canada | 1 | $197K |
| REGI - Commercialization and exportation | Canada Economic Development for Quebec Regions | 1 | $50K |
Agreements
Newest first.
| Start | Program | What for | Value |
|---|---|---|---|
| Apr 2026 | REGI - Commercialization and exportationCanada Economic Development for Quebec Regions | Contribution | $50,000 |
| May 2025 | Industrial Research Assistance ProgramNational Research Council Canada | Scale-up of a medical technology to treat breast cancer and its preclinical validation to treat breast cancer and skin cancer.Contribution | $197,000 |
| Jun 2021 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Validation of a unique high precision Cold Plasma Device for breast cancer treatment – Phase 3Contribution | $202,810 |
| Sep 2019 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Validation of a unique High Precision Cold Plasma Device as adjuvant for breast cancer radiotherapy Phase 2Contribution | $119,200 |
| Apr 2018 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Validation of a unique High Precision Cold Plasma Device as adjuvant for breast cancer radiotherapyContribution | $50,000 |